The Medtronic Sprint Fidelis® and Abbott Riata®/Riata ST® leads are at risk of failure and are subject to FDA recall. Comparative risks of various lead management strategies during elective generator change in a multi-center population are unknown. We aim to describe patients with functional, recalled ICD leads undergoing elective generator replacement and report outcomes according to lead management strategies.

中文翻译：

---

Riata 和 Fidelis 铅管理策略的比较结果：来自 NCDR-ICD 登记处的结果

Medtronic Sprint Fidelis® 和 Abbott Riata®/Riata ST® 引线有失败的风险，并受到 FDA 召回。在多中心人群的选择性发电机更换期间各种铅管理策略的比较风险尚不清楚。我们的目标是描述功能性、召回的 ICD 导联接受选择性发电机更换的患者，并根据导联管理策略报告结果。